Publication date: Jul 31, 2025
“We analyzed 29 adverse outcomes adapted from prioritized lists of adverse events of special interest to COVID-19 vaccines,” they wrote. “They found no statistically significant increases in the rate of hospital contacts for any of 29 adverse events during the 28-day period after patients received an mRNA vaccine. “The findings follow a national US poll in May that found only 56% of adults saying they were “somewhat confident” in COVID vaccine safety. “Each adverse event was analyzed separately.
| Concepts | Keywords |
|---|---|
| Adults | Adverse |
| Denmark | Analyzed |
| Myocarditis | Assessed |
| Vaccineeveryone | Ci |
| Covid | |
| Events | |
| Mrna | |
| Nationwide | |
| Outcomes | |
| Received | |
| Risk | |
| Safety | |
| Season | |
| Vaccine | |
| Vaccines |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | erythema multiforme |
| disease | MESH | transverse myelitis |
| disease | MESH | bleeding |
| disease | MESH | myocarditis |
| disease | MESH | inflammation |
| disease | IDO | blood |
| disease | MESH | cardiac events |
Original Article
(Visited 2 times, 1 visits today)